Long-term fate of terminally differentiated skeletal muscle cells following E1A-initiated cell cycle reactivation-Reference-Cited by-同舟云学术

Long-term fate of terminally differentiated skeletal muscle cells following E1A-initiated cell cycle reactivation

Published:2000-02 Issue:2 Volume:7 Page:145-154
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Latella L,Sacchi A,Crescenzi M

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/4400592.pdf

Reference24 articles.

1. Okazaki K and Holtzer H . (1966) Myogenesis: fusion, myosin synthesis, and the mitotic cycle. Proc. Natl. Acad. Sci. USA 56: 1484–1490

2. Fogel M and Defendi V . (1967) Infection of muscle cultures from various species with oncogenic DNA viruses (SV40 and polyoma). Proc. Natl. Acad. Sci. USA 58: 967–973

3. Yaffe D and Gershon D . (1967) Multinucleated muscle fibres: induction of DNA synthesis and mitosis by polyoma virus infection. Nature 215: 421–424

4. Graessmann A, Graessmann M and Fogel M . (1973) The relationship of polyoma virus-induced tumor (T) antigen to activation of DNA synthesis in rat myotubes. Dev. Biol. 35: 180–186

5. Endo T and Nadal-Ginard B . (1998) SV40 large T antigen induces reentry of terminally differentiated myotubes into the cell cycle. In Cellular and molecular biology of muscle development, Kedes LH and Stockdale FE, (eds). (New York: Alan R. Liss, Inc.) pp. 95–104

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restoring the Cell Cycle and Proliferation Competence in Terminally Differentiated Skeletal Muscle Myotubes;Cells;2021-10-14

2. Inhibitors of Tyrosine Phosphatases and Apoptosis Reprogram Lineage-Marked Differentiated Muscle to Myogenic Progenitor Cells;Chemistry & Biology;2011-09

3. DNA Replication Is Intrinsically Hindered in Terminally Differentiated Myotubes;PLoS ONE;2010-07-13

4. Molecular and Cellular Basis of Regeneration and Tissue Repair;Cellular and Molecular Life Sciences;2007-11-20

5. Bisperoxovanadium, a phospho‐tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype;The FASEB Journal;2007-06-29